NO970349L - Forbindelser som er anvendbare som antiproliferative midler og GARFT inhibitorer - Google Patents
Forbindelser som er anvendbare som antiproliferative midler og GARFT inhibitorerInfo
- Publication number
- NO970349L NO970349L NO970349A NO970349A NO970349L NO 970349 L NO970349 L NO 970349L NO 970349 A NO970349 A NO 970349A NO 970349 A NO970349 A NO 970349A NO 970349 L NO970349 L NO 970349L
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- antiproliferative agents
- compounds useful
- garft inhibitors
- garft
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 6
- 230000001028 anti-proliverative effect Effects 0.000 title abstract 3
- 239000003795 chemical substances by application Substances 0.000 title abstract 3
- 239000003944 phosphoribosylglycinamide formyltransferase inhibitor Substances 0.000 title abstract 3
- 150000003839 salts Chemical class 0.000 abstract 2
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/281,639 US5608082A (en) | 1994-07-28 | 1994-07-28 | Compounds useful as antiproliferative agents and GARFT inhibitors |
PCT/US1995/009519 WO1996003406A1 (en) | 1994-07-28 | 1995-07-28 | Compounds useful as antiproliferative agents and garft inhibitors |
Publications (3)
Publication Number | Publication Date |
---|---|
NO970349D0 NO970349D0 (no) | 1997-01-27 |
NO970349L true NO970349L (no) | 1997-03-12 |
NO308248B1 NO308248B1 (no) | 2000-08-21 |
Family
ID=23078167
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO970349A NO308248B1 (no) | 1994-07-28 | 1997-01-27 | Forbindelser som er anvendbare som antiproliferative midler og GARFT-inhibitorer, samt farmasøytisk preparat |
Country Status (20)
Country | Link |
---|---|
US (2) | US5608082A (no) |
EP (1) | EP0773943B1 (no) |
JP (1) | JPH10503762A (no) |
KR (1) | KR100380610B1 (no) |
CN (2) | CN1091770C (no) |
AT (1) | ATE206122T1 (no) |
AU (1) | AU697138B2 (no) |
CA (1) | CA2195420A1 (no) |
DE (1) | DE69522945T2 (no) |
DK (1) | DK0773943T3 (no) |
ES (1) | ES2162933T3 (no) |
FI (1) | FI112079B (no) |
MX (1) | MX9700675A (no) |
NO (1) | NO308248B1 (no) |
NZ (1) | NZ290703A (no) |
PT (1) | PT773943E (no) |
RU (1) | RU2152945C2 (no) |
SI (1) | SI0773943T1 (no) |
TW (1) | TW432062B (no) |
WO (1) | WO1996003406A1 (no) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5831100A (en) * | 1995-06-07 | 1998-11-03 | Agouron Pharmaceuticals, Inc. | Syntheses of optically pure compounds useful as GARFT inhibitors and their intermediates |
US6774138B2 (en) | 1999-08-31 | 2004-08-10 | Merck & Co., Inc. | Thiazolyl(pyridyl)ethyne compounds |
WO2001016121A1 (en) * | 1999-08-31 | 2001-03-08 | Merck & Co., Inc. | Heterocyclic compounds and methods of use thereof |
WO2002078709A2 (en) * | 2001-02-16 | 2002-10-10 | Eli Lilly And Company | Use of pyrido`2,3-d pyrimidin derivatives for the treatment of human cytomegalovirus infections |
WO2003033478A1 (en) * | 2001-10-12 | 2003-04-24 | Warner-Lambert Company Llc | Alkynylated fused ring pyrimidine compounds as matrix metalloprotease-13 inhibitors |
US6962922B2 (en) * | 2001-10-12 | 2005-11-08 | Warner-Lambert Company Llc | Alkynylated quinazoline compounds |
EP1434585A1 (en) | 2001-10-12 | 2004-07-07 | Warner-Lambert Company LLC | Alkyne matrix metalloproteinase inhibitors |
WO2003033477A1 (en) * | 2001-10-12 | 2003-04-24 | Warner-Lambert Company Llc | Alkynlated fused ring pyrimidine compounds as matrix metalloprotease-13 inhibitor |
US20040043959A1 (en) * | 2002-03-04 | 2004-03-04 | Bloom Laura A. | Combination therapies for treating methylthioadenosine phosphorylase deficient cells |
US6747147B2 (en) | 2002-03-08 | 2004-06-08 | Warner-Lambert Company | Oxo-azabicyclic compounds |
US6894057B2 (en) * | 2002-03-08 | 2005-05-17 | Warner-Lambert Company | Oxo-azabicyclic compounds |
US20040006077A1 (en) * | 2002-06-25 | 2004-01-08 | Bernard Gaudilliere | Thiazine and oxazine derivatives as MMP-13 inhibitors |
MXPA05000476A (es) * | 2002-07-17 | 2005-03-23 | Warner Lambert Co | Combinacion de un inhibidor alquino alosterico de metaloproteinasa-13 de matriz con celecoxib o valdecoxib. |
WO2004113328A1 (en) * | 2003-06-25 | 2004-12-29 | Pfizer Inc. | Convergent asymmetric synthesis route to produce a key intermediate towards the synthesis of a garft inhibitor |
WO2004113337A1 (en) * | 2003-06-25 | 2004-12-29 | Pfizer Inc. | Convergent synthesis of a garft inhibitor containing a methyl substitute thiophene core and a tetrahydropyrido`2,3-d! pyrimidine ring system and intermediates therefor |
WO2005016926A1 (en) * | 2003-08-19 | 2005-02-24 | Warner-Lambert Company Llc | Pyrido [3,4-d] pyrimidine derivatives as matrix metalloproteinase-13 inhibitors |
US7420059B2 (en) * | 2003-11-20 | 2008-09-02 | Bristol-Myers Squibb Company | HMG-CoA reductase inhibitors and method |
MX2007013304A (es) | 2005-04-26 | 2007-12-13 | Pfizer | Anticuerpos de p-caderina. |
PL2447283T3 (pl) | 2005-09-07 | 2015-12-31 | Amgen Fremont Inc | Ludzkie przeciwciała monoklonalne przeciwko kinazie podobnej do receptora aktywiny-1 (ALK-1) |
MEP43308A (en) | 2006-05-09 | 2011-02-10 | Pfizer Prod Inc | Cycloalkylamino acid derivatives and pharmaceutical compositions thereof |
US8252804B2 (en) * | 2008-10-01 | 2012-08-28 | Duquesne University Of The Holy Spirit | Selective proton coupled folate transporter and folate receptor, and GARFTase inhibitor compounds and methods of using the same |
MX343788B (es) | 2011-02-23 | 2016-11-23 | Lupin Ltd | Derivados de heteroarilo como moduladores de nachr alfa 7. |
GB201103578D0 (en) | 2011-03-02 | 2011-04-13 | Sabrepharm Ltd | Dipyridinium derivatives |
WO2013005153A1 (en) | 2011-07-05 | 2013-01-10 | Lupin Limited | Biaryl derivatives as nachr modulators |
EP2760820A4 (en) * | 2011-09-29 | 2015-04-29 | Univ Emory | SPHINGOSIN ANALOGS, COMPOSITIONS AND METHODS RELATED THERETO |
SG11201405239WA (en) | 2012-03-06 | 2014-09-26 | Lupin Ltd | Thiazole derivatives as alpha 7 nachr modulators |
GB2543550A (en) | 2015-10-21 | 2017-04-26 | Hox Therapeutics Ltd | Peptides |
CN115634228B (zh) * | 2021-07-20 | 2024-03-19 | 首都医科大学 | 嘌呤合成抑制剂在制备治疗缺血和缺血再灌注损伤药物中的应用 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT376436B (de) * | 1982-11-05 | 1984-11-26 | Laevosan Gmbh & Co Kg | Verfahren zur herstellung neuer thiophen-2carbons[urederivate und pharmazeutisch vertraeglicher saeure- oder basenadditionssalze davon |
US4684653A (en) * | 1985-03-08 | 1987-08-04 | The Trustees Of Princeton University | Pyrido(2,3-d)pyrimidine derivatives |
US5026851A (en) * | 1985-03-08 | 1991-06-25 | The Trustees Of Princeton University | Pyrido[2,3-]pyrimidine derivatives |
US4927828A (en) * | 1985-03-08 | 1990-05-22 | The Trustees Of Princeton University | Diastereoisomeric tetrahydropyrido-(2,3,d) pyrimidine derivatives |
US4831037A (en) * | 1987-04-20 | 1989-05-16 | The Trustees Of Princeton University | 4 (3H)-oxo-5,6,7,8-tetrahydropyrido-(2,3-d)pyrimidine derivatives |
US4988813A (en) * | 1986-10-20 | 1991-01-29 | The Trustees Of Princeton University | Process for the preparation of fused pyridine compounds |
US4895946A (en) * | 1987-10-26 | 1990-01-23 | The Trustees Of Princeton University | Process for the preparation of fused pyridine compounds |
US4889859A (en) * | 1988-02-05 | 1989-12-26 | The Trustees Of Princeton University | Pyrido[2,3-d]pyrimidine derivatives |
US4882334A (en) * | 1988-05-25 | 1989-11-21 | The Trustees Of Princeton University | N-(5,6,7,8-tetrahydropyrido]2,3-d]pyrimidin-6-ylethl-thineyl-and furylcarbonyl)-glutamic acid derivatives |
US4882333A (en) * | 1988-05-25 | 1989-11-21 | The Trustess Of Princeton University | N-(5,6,7,8-tetrahydropyrido[2,3-d]pyrimidin-6-yl-alkanoyl)-glutamic acid derivatives |
DK172753B1 (da) * | 1988-05-25 | 1999-06-28 | Lilly Co Eli | N-(5,6,7,8-tetrahydropyrido[2,3--d]pyrimidin-6-yl-alkanoyl)-glutaminsyrederivater, deres anvendelse, farmaceutiske præparat |
US4871746A (en) * | 1988-05-31 | 1989-10-03 | The Trustees Of Princeton University | N-[N-(tetrahydropyrido[2,3-D]pyrimidinylmethyl)-aminomethylbenzoyl]glutamic acid derivatives as neoplastic growth inhibitors |
US4883799A (en) * | 1988-06-29 | 1989-11-28 | The Trustees Of Princeton University | N-(4-(1-hydroxy-3-(5,6,7,8-tetrahydropyrido(2,3,-d)-pyrimidin-6-yl)prop-2-yl)benzoyl)glutamic acid derivatives |
EP0438261A3 (en) * | 1990-01-16 | 1992-02-26 | Takeda Chemical Industries, Ltd. | Condensed heterocyclic glutamic acid derivatives, their production and use |
IL99500A0 (en) * | 1990-09-17 | 1992-08-18 | Agouron Pharma | Naphthalene compounds,processes for the preparation thereof and pharmaceutical compositions containing the same |
US5217974A (en) * | 1991-03-29 | 1993-06-08 | Eli Lilly And Company | Method for treating gar-transformylase tumors in mammals and reducing mammalian toxicity |
US5223503A (en) * | 1991-04-29 | 1993-06-29 | Eli Lilly And Company | 6-substituted pyrido[2,3-d]pyrimidines as antineoplastic agents |
US5969136A (en) * | 1992-10-15 | 1999-10-19 | Eli Lilly And Company | Cyclization for preparing antifolate compounds |
DE69327796T2 (de) * | 1992-12-16 | 2000-06-21 | Agouron Pharmaceuticals , Inc. | Antiproliferative substituierte 5-thiapyrimidinon- und 5-selenopyrimidinonverbindungen |
-
1994
- 1994-07-28 US US08/281,639 patent/US5608082A/en not_active Expired - Fee Related
-
1995
- 1995-06-06 US US08/467,945 patent/US5646141A/en not_active Expired - Fee Related
- 1995-07-28 AT AT95927503T patent/ATE206122T1/de not_active IP Right Cessation
- 1995-07-28 WO PCT/US1995/009519 patent/WO1996003406A1/en active IP Right Grant
- 1995-07-28 CN CN95194376A patent/CN1091770C/zh not_active Expired - Fee Related
- 1995-07-28 PT PT95927503T patent/PT773943E/pt unknown
- 1995-07-28 ES ES95927503T patent/ES2162933T3/es not_active Expired - Lifetime
- 1995-07-28 DE DE69522945T patent/DE69522945T2/de not_active Expired - Fee Related
- 1995-07-28 EP EP95927503A patent/EP0773943B1/en not_active Expired - Lifetime
- 1995-07-28 SI SI9530534T patent/SI0773943T1/xx unknown
- 1995-07-28 AU AU31517/95A patent/AU697138B2/en not_active Ceased
- 1995-07-28 JP JP8505975A patent/JPH10503762A/ja not_active Withdrawn
- 1995-07-28 NZ NZ290703A patent/NZ290703A/en unknown
- 1995-07-28 KR KR1019970700588A patent/KR100380610B1/ko not_active IP Right Cessation
- 1995-07-28 MX MX9700675A patent/MX9700675A/es not_active IP Right Cessation
- 1995-07-28 RU RU97103518/04A patent/RU2152945C2/ru not_active IP Right Cessation
- 1995-07-28 CA CA002195420A patent/CA2195420A1/en not_active Abandoned
- 1995-07-28 DK DK95927503T patent/DK0773943T3/da active
-
1996
- 1996-01-29 TW TW085101051A patent/TW432062B/zh not_active IP Right Cessation
-
1997
- 1997-01-24 FI FI970317A patent/FI112079B/fi not_active IP Right Cessation
- 1997-01-27 NO NO970349A patent/NO308248B1/no not_active IP Right Cessation
-
2001
- 2001-12-05 CN CN01142735A patent/CN1394857A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
ES2162933T3 (es) | 2002-01-16 |
CN1154110A (zh) | 1997-07-09 |
CN1394857A (zh) | 2003-02-05 |
CN1091770C (zh) | 2002-10-02 |
JPH10503762A (ja) | 1998-04-07 |
RU2152945C2 (ru) | 2000-07-20 |
DK0773943T3 (da) | 2002-03-04 |
FI970317A (fi) | 1997-03-05 |
DE69522945T2 (de) | 2002-03-28 |
WO1996003406A1 (en) | 1996-02-08 |
ATE206122T1 (de) | 2001-10-15 |
TW432062B (en) | 2001-05-01 |
US5608082A (en) | 1997-03-04 |
SI0773943T1 (en) | 2001-12-31 |
KR100380610B1 (ko) | 2003-08-27 |
EP0773943B1 (en) | 2001-09-26 |
NO308248B1 (no) | 2000-08-21 |
NZ290703A (en) | 1998-11-25 |
AU3151795A (en) | 1996-02-22 |
FI112079B (fi) | 2003-10-31 |
FI970317A0 (fi) | 1997-01-24 |
AU697138B2 (en) | 1998-09-24 |
CA2195420A1 (en) | 1996-02-08 |
NO970349D0 (no) | 1997-01-27 |
MX9700675A (es) | 1997-04-30 |
DE69522945D1 (de) | 2001-10-31 |
US5646141A (en) | 1997-07-08 |
EP0773943A1 (en) | 1997-05-21 |
PT773943E (pt) | 2002-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO970349L (no) | Forbindelser som er anvendbare som antiproliferative midler og GARFT inhibitorer | |
DK0889877T3 (da) | Meta-substituerede phenylenderivater og deres anvendelse som alfav-beta3-integrin-antagonister eller -inhibitorer | |
DK0894084T3 (da) | Kanelsyrederivater og deres anvendelse som integrinantagonister | |
NO20025821L (no) | 2-aminokarbonyl-9H-purinderivater | |
ATE269312T1 (de) | N-(amidinophenyl)-n'-(subst.)-3h-2,4- benzodiazepin-3-on derivative als faktor xa inhibitoren | |
SE0302487D0 (sv) | Novel compounds | |
NO20050664L (no) | 2,4 substituerte indoler og anvendelse derav som 5-HT6 modulatorer | |
DK2314582T3 (da) | Heterocykliske forbindelser som antivirusmidler | |
NO20085077L (no) | Nye forbindelser | |
DE602004012758D1 (de) | Chinoxalinderivate als inhibitoren der neutrophilelastase und deren verwendung | |
MY143400A (en) | 2-pyridone derivatives as neutrophil elastase inhibitors and their use | |
NZ514477A (en) | Adamantane derivatives | |
DK1537104T3 (da) | Azabicycloalkylethere og deres anvendelse som alfa7-nAChR-agonister | |
DK0889876T3 (da) | Meta-substituerede phenylensulfonamidderivater | |
NO20025641D0 (no) | Substituerte 1-aminoalkyl-laktamer og deres anvendelse som muscarin-reseptor-antagonister | |
IL151172A0 (en) | Amine derivatives, their preparation and use as bax modulators | |
NO20025640D0 (no) | Substituerte 1-aminoalkyl-laktamer og deres anvendelse som muscarin-reseptor-antagonister | |
NO20040881L (no) | Orale antidiabetes midler. | |
NO20040589L (no) | Arylsulfonylderivater med 5-HT6 reseptor affinitet. | |
NO20000722L (no) | 2-(4-aryl eller heteroaryl-piperazin-1-ylmetyl)-1H- indolderivater | |
PT992509E (pt) | Novos derivados macrolidos | |
ATE505462T1 (de) | Neue biologischaktive molekü le | |
AR007108A1 (es) | Agentes antitumorales y antivirales alquilantes, procedimiento para su preparacion, utilizacion de los mismos para la fabricacion de un medicamento y composicion farmaceutica que contiene a dichos agentes. | |
DK0902018T3 (da) | 2-(arylpheny)amino-imidazolinderivater | |
NO983444D0 (no) | Benzo(c)kinolizin derivater, deres fremstilling og anvendelse som 5<alfa>-reduktaseinhibitorer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |